Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Director departure

DiaMedica Therapeutics Inc. (DMAC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: " "
07/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
06/30/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/02/2023 4 Daves Julie VanOrsdel (SVP Clinical Development Oper.) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 54,000 options to buy @ $2.73, valued at $147.4k
06/02/2023 4 Cundari Dominic R (Chief Commercial Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 27,000 options to buy @ $2.73, valued at $73.7k
06/02/2023 4 Gruis Kirsten L (Chief Medical Officer) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $2.73, valued at $182.9k
06/02/2023 4 Kellen Scott (CFO and Secretary) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 67,000 options to buy @ $2.73, valued at $182.9k
06/02/2023 4 Pauls Dietrich John (President and CEO) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 181,000 options to buy @ $2.73, valued at $494.1k
06/02/2023 4 Semba Charles Pauling (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 16,968 options to buy @ $2.73, valued at $46.3k
06/02/2023 4 Pilnik Richard D. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 22,355 options to buy @ $2.73, valued at $61k
06/02/2023 4 Parsons James T. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 16,968 options to buy @ $2.73, valued at $46.3k
05/30/2023 4 Kuntz Richard (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 32,320 options to buy @ $2.81, valued at $90.8k
05/30/2023 3 Kuntz Richard (Director) has filed a Form 3 on DiaMedica Therapeutics Inc.
05/18/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: " "
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
Docs: " "
04/18/2023 D Form D - Notice of Exempt Offering of Securities:
04/04/2023 ARS Form ARS - Annual Report to Security Holders:
04/04/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/04/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 8-K Quarterly results
03/17/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/10/2023 8-K Regulation FD Disclosure  Interactive Data
03/10/2023 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/06/2023 4 Lewis Tanya (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 26,443 options to buy @ $1.77, valued at $46.8k
03/06/2023 3 Lewis Tanya (Director) has filed a Form 3 on DiaMedica Therapeutics Inc.
03/06/2023 8-K Resignation/termination of a director
Docs: " "
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/13/2023 SC 13G/A JACINTO RICHARD II reports a 9.5% stake in DiaMedica Therapeutics Inc.
01/03/2023 4 Giuffre Randall Michael (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 35,130 shares @ $1.53, valued at $53.7k
01/03/2023 4 Burroughs Amy L. (Director) has filed a Form 4 on DiaMedica Therapeutics Inc.
Txns: Granted 17,156 shares @ $1.53, valued at $26.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy